WealthTrust Fairport’s Realm Therapeutics plc American Depositary Shares RLM Stock Holding History

WealthTrust Fairport’s Portfolio RLM Stock Details RLM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$9K	Hold	2,280	–	–	﹤0.01%	355
2018 Q4	$4K	Buy	+2,280	New	+$5.63K	﹤0.01%	372

Other funds holding RLM

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WealthTrust Fairport's RLM Position: Q1 2019 in Review

WealthTrust Fairport held its Realm Therapeutics plc American Depositary Shares (RLM) position steady in Q1 2019 at 2,280 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

WealthTrust Fairport first reported a position in RLM in Q4 2018 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold RLM as of Q1 2019.

WealthTrust Fairport held 2,280 shares of Realm Therapeutics plc American Depositary Shares worth $9K as of Q1 2019.
WealthTrust Fairport left its Realm Therapeutics plc American Depositary Shares share count unchanged in Q1 2019.
Realm Therapeutics plc American Depositary Shares made up ﹤0.01% of WealthTrust Fairport's portfolio in Q1 2019, its #355 holding.
WealthTrust Fairport first reported a position in Realm Therapeutics plc American Depositary Shares in Q4 2018 and has held it in 2 quarters since.
8 funds tracked by Wall St. Rank held Realm Therapeutics plc American Depositary Shares as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.